Abstract

A global gold standard framework for primary immunodeficiency (PID) care, structured around six principles, was published in 2014. To measure the implementation status of these principles IPOPI developed the PID Life Index in 2020, an interactive tool aggregating national PID data. This development was combined with a revision of the principles to consider advances in the field of health and science as well as political developments since 2014. The revision resulted in the following six principles: PID diagnosis, treatments, universal health coverage, specialised centres, national patient organisations and registries for PIDs. A questionnaire corresponding to these principles was sent out to IPOPI’s national member organisations and to countries in which IPOPI had medical contacts, and data was gathered from 60 countries. The data demonstrates that, regardless of global scientific progress on PIDs with a growing number of diagnostic tools and better treatment options becoming available, the accessibility and affordability of these remains uneven throughout the world. It is not only visible between regions, but also between countries within the same region. One of the most urgent needs is medical education. In countries without immunologists, patients with PID suffer the risk of remaining undiagnosed or misdiagnosed, resulting in health implications or even death. Many countries also lack the infrastructure needed to carry out more advanced diagnostic tests and perform treatments such as hematopoietic stem cell transplantation or gene therapy. The incapacity to secure appropriate diagnosis and treatments affects the PID environment negatively in these countries. Availability and affordability also remain key issues, as diagnosis and treatments require coverage/reimbursement to ensure that patients with PID can access them in practice, not only in theory. This is still not the case in many countries of the world according to the PID Life Index. Although some countries do perform better than others, to date no country has fully implemented the PID principles of care, confirming the long way ahead to ensure an optimal environment for patients with PID in every country.

Highlights

  • Primary immunodeficiencies (PIDs) are a large and growing group of over 450 [1] different disorders caused when components of the immune system are not working properly

  • The Index is a result of a reflection concerning the PID principles of care as published in 2014 [2], regarding how to assess the level of implementation of these principles as well as how to create a tool that captures the status of the PID healthcare environment in each country

  • According to the PID Life Index, 53 out of 54 countries responding to this principle provide at least one type of diagnostic test to its citizens

Read more

Summary

Introduction

Primary immunodeficiencies (PIDs) are a large and growing group of over 450 [1] different disorders caused when components of the immune system are not working properly. PIDs are related to inherited defects of the immune system (genetic or epigenetic). A normally functioning immune system maintains the integrity of the body, by fighting off infections by germs such as bacteria, viruses, fungi, and protozoa and tumour cells, and by keeping the internal homeostatic equilibrium. Because of their impaired immune system, people with PIDs are more prone to infections, autoimmune diseases and dysregulated inflammation than others. When PIDs are left underdiagnosed or are misdiagnosed, the defective immune system leads to illness, disability, permanent organ damage and even death [2]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call